AU Stock MarketDetailed Quotes
IVX Invion Ltd
- 0.004
- +0.001+33.33%
20min DelayMarket Closed Oct 4 16:00 AET
27.07MMarket Cap-4000P/E (Static)
0.004High0.003Low3.20MVolume0.003Open0.003Pre Close9.70KTurnover0.00852wk High0.08%Turnover Ratio6.77BShares0.00252wk Low-0.001EPS TTM15.65MFloat Cap0.674Historical HighLossP/E (Static)3.91BShs Float0.002Historical Low-0.001EPS LYR33.33%Amplitude--Dividend TTM2.00P/B1Lot Size--Div YieldTTM
About Invion Ltd Company
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer.
Company Profile
SymbolIVX
Company NameInvion Ltd
Founded2000
MarketASX
Employees7
Fiscal Year Ends06-30
Address692 High Street
CityEast Kew
CountryAustralia
Zip Code3102
Websitehttps://www.inviongroup.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- Chiat Thian Chew
- Executive Chairman of the Board and Chief Executive Officer
- --
- Alistair Bennallack
- Non-Executive Director
- --
- Alan Yamashita
- Non-Executive Director
- --
- Robert (Rob) Merriel
- Non-Executive Director
- --
- Tai Phan
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data